PRODUCT NAME:

Product Name: Methotrexate CLIA Kit (Chemiluminescence Immunoassay) Abbreviation: MTX 

INTENDED USE:

Methotrexate CLIA Kit (Chemiluminescence Immunoassay) is an in vitro diagnostic test for the quantitative detection of Methotrexate (MTX) in human serum and plasma specimen. This product is intended to be used by laboratory professional workers only. This kit is used for auxiliary diagnosis. Results must be combined with clinical observations, patient history, other laboratory parameters, and epidemiological information. Methotrexate is a folic acid antitumor drug, which is widely used in the clinical treatment of acute lymphoblastic leukemia, lymphoma, choriocarcinoma and osteosarcoma and other malignant tumors. High-dose methotrexate combined with calcium leucovorin is one of the important treatment options for acute lymphoblastic leukemia, malignant lymphoma, and osteosarcoma. High-dose methotrexate chemotherapy needs to monitor the MTX blood concentration to guide the rational use of drugs and avoid serious toxic and side effects to patients. Therefore, the monitoring of methotrexate blood concentration is of great significance for guiding the clinical rational drug use in cancer patients.